Some discomfort is normal, but pain is usually manageable with medication. Recovery varies based on the surgical method used.

CRRT is a medical therapy used in intensive care units to manage patients with acute kidney injury (AKI) or severe kidney dysfunction. It involves the continuous removal of waste products and excess fluids from the blood.

CRRT is used when a patient’s kidneys are unable to adequately filter waste and excess fluids from the blood, leading to dangerous levels of toxins and fluid overload.

CRRT differs from hemodialysis in that it is slower and performed continuously over 24 hours or longer periods. Hemodialysis, on the other hand, is intermittent and typically lasts for a few hours.

Yes, CRRT can be used cautiously in patients with heart failure to manage fluid overload and electrolyte imbalances, with careful monitoring of hemodynamic status.

CRRT provides gentler and more gradual fluid and solute removal, making it suitable for hemodynamically unstable patients who cannot tolerate the rapid changes associated with conventional hemodialysis.

G6PD deficiency is a genetic disorder that affects the red blood cells, making them more vulnerable to breaking down prematurely.

Symptoms such as fatigue, jaundice, dark urine, or a family history of G6PD deficiency may indicate the need for this test.

The G6PD test is a simple blood test with minimal risks, similar to any standard blood draw.

Management includes avoiding triggers such as certain medications, foods, and infections that can cause hemolysis.

Early detection in newborns can prevent severe jaundice and related complications by guiding appropriate care and dietary adjustments.